Biotech Acquisition Co. is a blank check company, which engages in the effectuation of a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one business. The company was founded on September 3, 2020 and is headquartered in New York, NY.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Biotech Acquisition Co - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Biotech Acquisition Co - Ordinary Shares - Class A market cap is $291.81M.
What is the 52-week high for Biotech Acquisition Co - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Biotech Acquisition Co - Ordinary Shares - Class A 52 week high is $10.41 as of September 06, 2025.
What is the 52-week low for Biotech Acquisition Co - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Biotech Acquisition Co - Ordinary Shares - Class A 52 week low is $8.30 as of September 06, 2025.
What is Biotech Acquisition Co - Ordinary Shares - Class A stock price today?
Biotech Acquisition Co - Ordinary Shares - Class A stock price today is $10.16.
What was Biotech Acquisition Co - Ordinary Shares - Class A stock price yesterday?
Biotech Acquisition Co - Ordinary Shares - Class A stock price yesterday was $10.23.
What is the PE ratio of Biotech Acquisition Co - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Biotech Acquisition Co - Ordinary Shares - Class A’s P/E ratio is 36.30.
What is the Price-to-Book ratio of Biotech Acquisition Co - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Biotech Acquisition Co - Ordinary Shares - Class A P/B ratio is 1.3375.
What is the 50-day moving average of Biotech Acquisition Co - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Biotech Acquisition Co - Ordinary Shares - Class A 50-day moving average is $10.11.
